Human immunodeficiency virus long terminal repeat
Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence.
9
Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat.
5
In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat
7
Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.
7
Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.
6
Mycobacterium tuberculosis enhances human immunodeficiency virus 1 replication by transcriptional activation at the long terminal repeat
9
Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
8
Methylation as a modulator of expression of human immunodeficiency virus.
5
Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements.
9
Mutational analysis of the equine infectious anemia virus Tat-responsive element.
7
Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.
5
Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.
6
Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells.
9
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.
11
Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1.
5
Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication.
5
Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.
10
Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.
5
Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
10
Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.
11